Myelodysplastic Syndromes (MDS) Clinical Trials

A listing of Myelodysplastic Syndromes (MDS) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Colorado

Aurora Colorado 80045

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

Illinois

Chicago Illinois 60637

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

Chicago Illinois 60637

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Maryland

Baltimore Maryland 21201

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Massachusetts

Boston Massachusetts 02215

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

Boston Massachusetts 022115

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Boston Massachusetts 02111

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Missouri

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

New York

View More ▼

New York New York 10032

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

New York New York 10032

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

North Dakota

Pennsylvania

Pittsburgh Pennsylvania 15232

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Tennessee

Nashville Tennessee 37232

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Texas

Houston Texas 77030

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Australia

Brisbane 4102

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Concord 2139

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Fitzroy 3065

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

Heidelberg 3084

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Kogarah 2217

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

View More ▼

Kogarah 2217

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Melbourne 3050

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

Prahran 3181

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Warratah 2298

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Canada

Hamilton L8V 1C3

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Montreal H3T 1E2

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

France

Paris 75010

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Germany

Cologne 50937

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Halle 06120

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

Halle 06120

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Leipzig 04103

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Mannheim 68167

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

View More ▼

Munich 81675

A clinical research study of venetoclax and azacitidine for the treatment of Myelodysplastic Syndromes (MDS)

Munich 81675

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Italy

Bologna 40138

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Rome 00161

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

United Kingdom

Birmingham B9 5SS

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

London SE5 9RS

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Norwich NR4 7UY

A clinical trial to evaluate treatments using Venetoclax and Azacitidine for patients with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)